What is PlushCare?
Founded in 2014, PlushCare operates as a comprehensive virtual health platform that bridges the gap between patients and physicians from top-tier medical institutions. The company provides a seamless digital experience for primary care, including diagnosis, treatment, medication management, and laboratory testing. By integrating with major insurance providers and offering same-day appointment availability, PlushCare has effectively disrupted traditional healthcare delivery models. Its dual-market approach, serving both B2B and B2C segments, positions the company as a critical infrastructure provider in the modern healthcare economy, emphasizing convenience without compromising clinical quality.
How much funding has PlushCare raised?
PlushCare has raised a total of $31M across 2 funding rounds:
Series A
$8M
Series B
$23M
Series A (2016): $8M with participation from Lightspeed Venture Partners, Exponent, and GGV Capital
Series B (2020): $23M led by GGV Capital, Western Technology Investment, and Transformation Capital
Key Investors in PlushCare
GGV Capital
A global venture firm with a multi-stage focus, GGV Capital invests in high-growth sectors including enterprise tech and smart tech, leveraging a deep history of backing transformative global companies.
Lightspeed Venture Partners
A premier multistage venture capital firm that partners with founders from the seed stage through to IPO, specializing in enterprise software, fintech, and infrastructure.
Western Technology Investment
A specialized firm focused on providing venture debt to innovation-driven companies, helping startups finance growth while minimizing shareholder dilution.
What's next for PlushCare?
With the support of major enterprise-level funding, PlushCare is well-positioned to accelerate its strategic initiatives in the competitive telehealth sector. Future growth will likely focus on deepening its B2B partnerships and enhancing its proprietary technology stack to support more complex diagnostic capabilities. As the demand for remote healthcare services continues to normalize, the company's ability to maintain its high standard of care while scaling operations will be a key determinant of its long-term success. Investors remain optimistic about the firm's potential to further integrate into the broader healthcare continuum, potentially exploring new avenues in chronic disease management and preventative health services.
See full PlushCare company page
